» Articles » PMID: 19934081

Role of CX3C-chemokine CX3C-L/fractalkine Expression in a Model of Slowly Progressive Renal Failure

Overview
Date 2009 Nov 26
PMID 19934081
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The chemokine/chemokine receptor pair CX(3)C-L/CX(3)C-R is suspected to play a role in renal fibrogenesis. The aim of this study was to investigate their function in an animal model of slowly progressive chronic renal failure.

Methods: Functional data were analysed in folic acid nephropathy (FAN) at different time points (up to day 142 after induction). Immunostaining for CX(3)C-L, CD3, S100A4, collagen type I, fibronectin, alpha-smooth muscle actin, Tamm-horsfall protein, aquaporin 1 and 2 as well as quantitative real-time PCR (qRT-PCR) for CX(3)C-L, CX(3)C-R and fibroblast-specific protein 1 (FSP-1) were performed. Additionally, regulatory mechanisms and functional activity of CX(3)C-L in murine proximal and distal tubular epithelial cells as well as in fibroblasts were investigated.

Results: CX(3)C-L/GAPDH ratio was upregulated in FAN 3.4-fold at day 7 further increasing up to 7.1-fold at day 106. The expression of mRNA CX(3)C-L correlated well with CX(3)C-R (R(2) = 0.96), the number of infiltrating CD3+ cells (R(2) = 0.60) and the degree of tubulointerstitial fibrosis (R(2) = 0.56) and moderately with FSP-1 (R(2) = 0.33). Interleukin-1beta, tumour necrosis factor-alpha, transforming growth factor-beta as well as the reactive oxygen species (ROS) H(2)O(2) were identified by qRT-PCR as inductors of CX(3)C-L/fractalkine (FKN) in tubular epithelial cells. Functionally, CX(3)C-L/FKN chemoattracts peripheral blood mononuclear cells, activates several aspects of fibrogenesis and induces the mitogen-activated protein kinases in renal fibroblasts.

Conclusions: In FAN, there is a good correlation between the expression of CX(3)C-L with markers of interstitial inflammation and fibrosis which may result from upregulation by pro-inflammatory and pro-fibrotic cytokines as well as by ROS in tubular epithelial cells. The FKN system may promote renal inflammation and renal fibrogenesis.

Citing Articles

Evaluation of Cisplatin-Induced Acute Renal Failure Amelioration Using Fondaparinux and Alteplase.

Abdel-Bakky M, Aldakhili A, Ali H, Babiker A, Alhowail A, Mohammed S Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513824 PMC: 10383028. DOI: 10.3390/ph16070910.


Use of novel structural features to identify urinary biomarkers during acute kidney injury that predict progression to chronic kidney disease.

Charlton J, Li T, Wu T, deRonde K, Xu Y, Baldelomar E BMC Nephrol. 2023; 24(1):178.

PMID: 37331957 PMC: 10278294. DOI: 10.1186/s12882-023-03196-0.


CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome.

Zheng C, Xuan W, Chen Z, Zhang R, Huang X, Zhu Y Front Pharmacol. 2022; 13:848310.

PMID: 35370759 PMC: 8971671. DOI: 10.3389/fphar.2022.848310.


A single-domain i-body, AD-114, attenuates renal fibrosis through blockade of CXCR4.

Cao Q, Huang C, Yi H, Gill A, Chou A, Foley M JCI Insight. 2022; 7(4).

PMID: 35015734 PMC: 8876455. DOI: 10.1172/jci.insight.143018.


The Role of Chemokines in Cardiovascular Diseases and the Therapeutic Effect of Curcumin on CXCL8 and CCL2 as Pathological Chemokines in Atherosclerosis.

Hedayati-Moghadam M, Hosseinian S, Paseban M, Shabgah A, Gholizadeh J, Jamialahmadi T Adv Exp Med Biol. 2022; 1328:155-170.

PMID: 34981477 DOI: 10.1007/978-3-030-73234-9_11.